A healthy donor corneal tissue is mandatory for successful keratoplasty. Thus, robust screening protocols are followed to reduce the risk of grafting diseased or flawed tissues. These include detailed scrutiny of donors' medical histories, thorough slit lamp examination of donated tissue and donor risk assessment interviews with those persons who knew the donor well. However, these processes at times can be lacking and donors who have previously undergone laser refractive surgery have in the past, escaped detection.\[[@ref1]\] We report a series of three cases in which unexplained anterior stromal scars were detected postoperatively in donor corneal tissues.

Case Reports {#sec1-2}
============

Three illustrative cases involving patients whose donor grafts were found to have anterior stromal scarring following uncomplicated corneal transplantation surgery were identified in the outpatient clinics.

In all cases, corneal tissue was obtained from donors in Melbourne, Australia. Following standard consent, tissue was retrieved as corneoscleral rims, with screening and preparation performed at the Lions Eye Donation Service, Melbourne, Australia. The standards and guidelines of the Eye Bank Association of Australia and New Zealand\[[@ref2]\] and the Therapeutic Goods Administration of Australia\[[@ref3][@ref4]\] were employed and followed. Donor history was obtained from hospital medical records and from medical records of the donor family physician. Further history was obtained from a knowledgeable historian during a donor risk assessment interview, which included explicit questions regarding previous ocular surgery, pathology, refractive procedures, or therapies. All corneoscleral discs underwent routine screening, which included *in situ* penlight examination, slit lamp biomicroscopy examination of the excised corneoscleral disc, specular microscopy of the endothelium, placement into organ culture preservation media with repeat microbiological testing, and light microscopy examination at the end of the storage period. Reported demographic and clinical data were taken from clinic and eye bank medical records.

Case 1 {#sec2-1}
------

A 40-year-old male presented with a history of advanced keratoconus affecting his right eye. His right and left best corrected visual acuities (BCVA) were 20/200 (6/60) and 20/20 (6/6), respectively. A predescemetic deep anterior lamellar keratoplasty (DALK), using a Dia-DALK technique,\[[@ref5]\] was successfully performed in his right eye. At one week postoperatively, a well-defined anterior stromal scar was detected in the grafted cornea. This finding was confirmed by anterior segment optical coherence tomography (AS-OCT) \[[Fig. 1](#F1){ref-type="fig"}\].

![Anterior segment optical coherence tomography demonstrating a well-defined anterior stromal scar in donor graft](IJO-67-1889-g001){#F1}

No history of corneal surgery, pathology, or infection was identified on initial screening of the donor. The donor age was 24 yrs and tissue was PK grade with Endothelial Cell density of 3383 cells/mm^2^. The patient was informed of this unusual postoperative finding and following lengthy discussion, a graft exchange was successfully performed. The abnormal graft tissue was sent for histopathologic examination which revealed dense hypocellular fibrosis with hyaline change, associated with embedded shaft-like foreign bodies. At 12-months following graft exchange surgery, the patient\'s right BCVA was 20/30 (6/9).

Case 2 {#sec2-2}
------

A 25-year-old female underwent an attempted big bubble DALK to treat keratoconus in her left eye. Intraoperatively, an unsalvageable perforation occurred and the procedure was converted to a penetrating keratoplasty (PK). At the 6-week postoperative follow-up, a well-defined anterior stromal scar was detected in the donor cornea upon slit lamp examination \[[Fig. 2a](#F2){ref-type="fig"}\], which was subsequently confirmed by anterior segment OCT (AS-OCT) \[[Fig. 2b](#F2){ref-type="fig"}\]. As the patient\'s left BCVA was 6/9, the decision was made to manage conservatively and observe. Initial screening of the donor, including a donor risk assessment interview, did not reveal any significant findings nor did a review of the donor\'s medical history. The endothelial cell density of donor cornea was 3200 cells/mm^2^ and was PK Grade tissue with donor age being 21 yrs.

![(a) Slit lamp photography demonstrating stromal corneal haze. (b) The same lesion demonstrated on anterior segment optical coherence tomography](IJO-67-1889-g002){#F2}

Case 3 {#sec2-3}
------

A 30-year-old male, presented with advanced keratoconus in his left eye. His right and left BCVA were 20/30 (6/9) and 20/200 (6/60), respectively. A successful Dia-DALK\[[@ref5]\] was performed in his left eye and both the surgery and postoperative course were unremarkable. A diffuse anterior stromal haze was noted within the graft at the four-week follow-up, which was further characterized by AS-OCT, revealing a well-defined anterior stromal scar extending across the donor cornea \[[Fig. 3](#F3){ref-type="fig"}\]. The patient was informed of this finding and the decision was made to manage conservatively and monitor the lesion due to the patient\'s excellent visual acuity which was 20/40 (6/12). At 1 year, the patient\'s left BCVA was 20/20 (6/6). Neither the initial screening of the donor, including the donor risk assessment interview, nor did a review of the donor\'s medical history reveal any significant findings. The donor was 50 years old and the corneal tissue had an endothelial density of 2985 cells/mm^2^.

![Anterior segment optical coherence tomography demonstrating an anterior stromal opacity](IJO-67-1889-g003){#F3}

Discussion {#sec1-3}
==========

There are many reports in the literature of unhealthy donor tissue escaping the screening processes of eye banks,\[[@ref1][@ref6]\] indicating that the current screening protocols practiced by many eye banks may not be able to detect pathologies such corneal scars or previous corneal laser refractive surgery scars.

Subtle corneal pathologies may be difficult to detect in donor tissue due to the development of stromal edema and epithelial degradation prior to tissue collection. The challenges faced by eye banks in screening donor tissues for difficult-to-detect pathologies, such as a previous laser-assisted *in situ* keratomileusis (LASIK) surgery, have been highlighted.\[[@ref7]\] In comparison to histological examination, when screened on history or slit lamp examination alone, the rate of misidentification of previous LASIK surgery in donor tissue was found to be 13.5% and 18.2%, respectively. Even when donor tissue was screened using a combination of history and slit lamp examination, the rate of misidentification was still 3.4%. It is significant then that in all the cases we report here, that no ophthalmic history was identified in the donor, including when direct and specific questions were asked of the knowledgeable historians on previous eye surgery, refractive procedures, or vision correcting procedures.

Given these difficulties, screening methods must be refined to decrease the risk of transplanting suboptimal donor tissue and implementing the use of OCT may be of benefit in enhancing the screening process. A laboratory-based study has demonstrated the ability of OCT to consistently detect the flap-stromal interface following LASIK surgery.\[[@ref8]\]

OCT has also been found to detect a range of stromal opacities.\[[@ref9]\] Bald *et al.* examined seven corneas, found to have anterior stromal opacities on slit lamp examination, with OCT.\[[@ref9]\] Significantly, this resulted in the diagnoses of two cases being revised. The first involved a cornea in which a presumed stromal opacity was found to be localized to the epithelium, while the second involved a cornea in which a presumed epithelial opacity was found to be localized to the stroma.

In conclusion, anterior stromal corneal pathologies may remain undetected by current eye bank screening protocols that do not use corneal OCT. Therefore, it is recommended to incorporate AS-OCT imaging of donor corneal tissue into routine eye bank screening procedures to minimize the risk of suboptimal tissue being accepted for transplantation.
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